HOME >> BIOLOGY >> NEWS
Blood banking systems improving in China, more progress needed

After years spent analyzing blood banking and transfusion practices in China, a Johns Hopkins-led research team says that major improvements are needed to ensure the safety and reliability of the blood supply that serves 20 percent of the world's population.

"There have been advances over the last few years, but with one of the fastest growing rates of HIV infection, the shortcomings of the systems used to collect blood and screen it for HIV and hepatitis B and C indicate that if improvements aren't developed quickly, China could find itself on the upslope of transfusion-borne infection," says Hua Shan, M.D., assistant professor of pathology, associate medical director in transfusion medicine and associate medical director of the HIV Specialty Testing Laboratory at Johns Hopkins.

"The Chinese government recognizes the country's need in this area and is asking for help, and it's vital to China and the world that help is provided," she adds.

The Johns Hopkins researchers and their Chinese colleagues published an analysis of the country's blood banking systems -- from how blood donors are recruited to how blood products are given to patients -- in the British journal The Lancet last fall.

"Problems like those seen in China's blood banking system are common in countries without infrastructure, means or expertise in this area, and they are critical problems for public health," notes Paul Ness, M.D., director of transfusion medicine at Johns Hopkins and an author of the study. "We hope improvements in China's system might be adopted or translated to address similar issues elsewhere."

Working closely with the Chinese Ministry of Health and with blood banking and transfusion organizations in China, the researchers hope their study will provide the most comprehensive, single source of reliable information about the systems currently in place, making it possible to identify the country's needs and develop workable solutions. <
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
15-Jan-2003


Page: 1 2 3

Related biology news :

1. Blood pressure hormone may inhibit growth of lung cancer
2. Blood tests identify patients on dialysis at high risk for death from cardiovascular disease
3. Blood proteins tied to inflammation
4. Bloodworms way with copper likely provides paradigm for new materials
5. Blood markers may reflect newborns potential of contracting HIV
6. Blood stem cells carry targeted genes
7. Blood vessels trigger development of the pancreas
8. Blood vessels found to signal chain of destruction in bone diseases
9. Blood markers associated with autism and mental retardation
10. Blood test for diagnosing schizophrenia
11. Blood pressure-lowering DASH diet also reduces homocysteine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Club. The event entitled “Stem Cells and Their Regenerative Powers,” was ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., ...
Breaking Biology Technology:
Cached News: